Your browser doesn't support javascript.
loading
Correction: MIR22HG acts as a tumor suppressor via TGFß/SMAD signaling and facilitates immunotherapy in colorectal cancer.
Xu, Juan; Shao, Tingting; Song, Mingxu; Xie, Yunjin; Zhou, Jialiang; Yin, Jiaqi; Ding, Na; Zou, Haozhe; Li, Yongsheng; Zhang, Jiwei.
Afiliação
  • Xu J; Key Laboratory of Tropical Translational Medicine of Ministry of Education, College of Biomedical Information and Engineering, Hainan Medical University, Haikou, 571199, China. xujuanbiocc@ems.hrbmu.edu.cn.
  • Shao T; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China. xujuanbiocc@ems.hrbmu.edu.cn.
  • Song M; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Xie Y; Wuxi Oncology Institute, The Affiliated Hospital of Jiangnan University, Wuxi, 214062, China.
  • Zhou J; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Yin J; Department of radiation oncology, The Affiliated Hospital of Jiangnan University, Wuxi, 214062, China.
  • Ding N; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Zou H; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Li Y; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, 150081, China.
  • Zhang J; Key Laboratory of Tropical Translational Medicine of Ministry of Education, College of Biomedical Information and Engineering, Hainan Medical University, Haikou, 571199, China. liyongsheng@hainmc.edu.cn.
Mol Cancer ; 22(1): 116, 2023 Jul 20.
Article em En | MEDLINE | ID: mdl-37474972

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Mol Cancer Ano de publicação: 2023 Tipo de documento: Article